Debate: Targeted therapy for RAS/BRAF WT left sided colon cancers - EGFR antibodies are mandatory - 100004

Spotlight
Video

Debate: Targeted therapy for RAS/BRAF WT left sided colon cancers - EGFR antibodies are mandatory

imedex has 1207 videos Subscribe Here

Loading........
Description: In this presentation from the 2017 Great Debates & Updates in GI Malignancies, Dr. Eric Van Cutsem argues that EGFR antibodies are mandatory targeted therapy for RAS/BRAF wild-type left sided colon cancers.

Earn CME Credit for a related activity: http://elc.imedex.com/ELC/S...

© 2017 Imedex, LLC.
Shared By : imedex
Posted on : 10/13/17
Added : 3 months ago



Recommended

Nothing found.